Cellular Biomedicine Group Inc

NASDAQ:CBMG   3:59:41 PM EDT
18.62
+0.18 (+0.98%)
Earnings Announcements

Cellular Biomedicine Group Reports Q3 2020 Financial Results

Published: 11/09/2020 22:48 GMT
Cellular Biomedicine Group Inc (CBMG) - Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business Highlights.
Cellular Biomedicine Group Inc - Qtrly Loss per Share $0.88.
Revenue is expected to be $0.5 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.63

More details on our Analysts Page.